Supplementation with B vitamins or n-3 fatty acids and depressive symptoms in cardiovascular disease survivors: ancillary findings from the SUpplementation with FOLate, vitamins B-6 and B-12 and/or OMega-3 fatty acids (SU.FOL.OM3) randomized trial
- PMID: 22648722
- DOI: 10.3945/ajcn.112.035253
Supplementation with B vitamins or n-3 fatty acids and depressive symptoms in cardiovascular disease survivors: ancillary findings from the SUpplementation with FOLate, vitamins B-6 and B-12 and/or OMega-3 fatty acids (SU.FOL.OM3) randomized trial
Abstract
Background: Dietary factors might affect depressive symptoms.
Objective: In secondary data analyses, we examined effects of supplementation with B vitamins or n-3 (omega-3) fatty acids on depressive symptoms in cardiovascular disease survivors.
Design: The SUpplementation with FOLate, vitamins B-6 and B-12 and/or OMega-3 fatty acids (SU.FOL.OM3) trial was a secondary prevention trial (2003-2009; n = 2501) in which individuals aged 45-80 y were randomly assigned, by using a 2 × 2 factorial design, to receive 0.56 mg 5-methyl-tetrahydrofolate and vitamins B-6 (3 mg) and B-12 (0.02 mg); EPA and DHA (600 mg) in a 2:1 ratio; B vitamins and n-3 fatty acids; or a placebo. Depressive symptoms were evaluated at years 3 and 5 with the 30-item Geriatric Depression Scale (GDS). Overall and sex-specific ORs and 95% CIs were estimated in 2000 participants by using factorial logistic regression.
Results: After a median of 4.7 y of supplementation, there was no association between allocation to receive B vitamins and depressive symptoms. However, the allocation to receive n-3 fatty acids was positively associated with depressive symptoms (GDS >10) in men (adjusted OR: 1.28; 95% CI: 1.03, 1.61) but not in women.
Conclusions: We showed no beneficial effects of a long-term, low-dose supplementation with B vitamins or n-3 fatty acids on depressive symptoms in cardiovascular disease survivors. The adverse effects of n-3 fatty acids in men merit confirmation.
Similar articles
-
B vitamin and/or ω-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial.Arch Intern Med. 2012 Apr 9;172(7):540-7. doi: 10.1001/archinternmed.2011.1450. Epub 2012 Feb 13. Arch Intern Med. 2012. PMID: 22331983 Clinical Trial.
-
B vitamin and/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial.PLoS One. 2014 Jan 17;9(1):e84844. doi: 10.1371/journal.pone.0084844. eCollection 2014. PLoS One. 2014. PMID: 24465438 Free PMC article. Clinical Trial.
-
Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial.Am J Clin Nutr. 2011 Jul;94(1):278-86. doi: 10.3945/ajcn.110.006320. Epub 2011 May 18. Am J Clin Nutr. 2011. PMID: 21593490 Clinical Trial.
-
Do B Vitamins Enhance the Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases? A Systematic Review of Clinical Trials.Nutrients. 2022 Apr 12;14(8):1608. doi: 10.3390/nu14081608. Nutrients. 2022. PMID: 35458173 Free PMC article. Review.
-
Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.Arch Intern Med. 2012 May 14;172(9):686-94. doi: 10.1001/archinternmed.2012.262. Arch Intern Med. 2012. PMID: 22493407 Review.
Cited by
-
Comments on Bozzatello et al. Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data. J. Clin. Med. 2016, 5, 67.J Clin Med. 2016 Aug 3;5(8):69. doi: 10.3390/jcm5080069. J Clin Med. 2016. PMID: 27527228 Free PMC article.
-
Inflammatory cytokine-associated depression.Brain Res. 2015 Aug 18;1617:113-25. doi: 10.1016/j.brainres.2014.06.032. Epub 2014 Jul 5. Brain Res. 2015. PMID: 25003554 Free PMC article. Review.
-
Marine-derived n-3 fatty acids therapy for stroke.Cochrane Database Syst Rev. 2022 Jun 29;6(6):CD012815. doi: 10.1002/14651858.CD012815.pub3. Cochrane Database Syst Rev. 2022. PMID: 35766825 Free PMC article. Review.
-
Psychological and pharmacological interventions for depression in patients with coronary artery disease.Cochrane Database Syst Rev. 2021 Dec 15;12(12):CD008012. doi: 10.1002/14651858.CD008012.pub4. Cochrane Database Syst Rev. 2021. PMID: 34910821 Free PMC article. Review.
-
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2018 Nov 30;11(11):CD003177. doi: 10.1002/14651858.CD003177.pub4. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2020 Feb 29;3:CD003177. doi: 10.1002/14651858.CD003177.pub5 PMID: 30521670 Free PMC article. Updated.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
Research Materials